Skip to content

ENDOCYTE INC: 10-K filed 2014-03-05

What ENDOCYTE INC reported in its annual report filed 2014-03-05 (fiscal FY 2013): 32 published measures, 133 facts as tagged in accession 0001144204-14-013535.

This filing

Form
10-K (annual report)
Filed
2014-03-05
Fiscal period
fiscal FY 2013
Accession
0001144204-14-013535 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENDOCYTE INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-31162,857,576USD
At 2012-12-31214,078,709USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3174,628,855USD
At 2012-12-31114,505,431USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3188,228,721USD
At 2012-12-3199,573,278USD
At 2011-12-31113,371,923USD
At 2010-12-31-96,911,023USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3152,846,940USD
At 2012-12-3133,996,866USD
At 2011-12-3161,352,483USD
At 2010-12-3116,872,783USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-2,902USD92
2013-01-01 to 2013-12-31-18,032,438USD365
2013-07-01 to 2013-09-30-3,041USD92
2013-04-01 to 2013-06-30-8,227USD91
2013-01-01 to 2013-03-31-3,862USD90
2012-10-01 to 2012-12-31-849USD92
2012-01-01 to 2012-12-31-17,291,758USD366
2012-07-01 to 2012-09-30-1,239USD92
2012-04-01 to 2012-06-30-5,434USD91
2012-01-01 to 2012-03-31-9,770USD91
2011-01-01 to 2011-12-31-40,531,613USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-12-31827,839USD365
2012-01-01 to 2012-12-311,862,872USD366
2011-01-01 to 2011-12-31234,969USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-10-01 to 2013-12-3117,274USD92
2013-01-01 to 2013-12-3164,870,919USD365
2013-07-01 to 2013-09-3016,600USD92
2013-04-01 to 2013-06-3016,483USD91
2013-01-01 to 2013-03-3114,514USD90
2012-10-01 to 2012-12-3114,454USD92
2012-01-01 to 2012-12-3134,682,111USD366
2012-07-01 to 2012-09-3012,415USD92
2012-04-01 to 2012-06-307,813USD91
2012-01-01 to 2012-03-310USD91
2011-01-01 to 2011-12-31191,023USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-173,924,716USD
At 2012-12-31-155,892,278USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-313,839,426USD
At 2012-12-313,166,905USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-316,059,005USD365
2012-01-01 to 2012-12-313,022,693USD366
2011-01-01 to 2011-12-311,960,345USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-2,963USD92
2013-01-01 to 2013-12-31-18,341,783USD365
2013-07-01 to 2013-09-30-3,044USD92
2013-04-01 to 2013-06-30-8,335USD91
2013-01-01 to 2013-03-31-4,001USD90
2012-10-01 to 2012-12-31-1,014USD92
2012-01-01 to 2012-12-31-16,042,676USD366
2012-07-01 to 2012-09-30-1,330USD92
2012-04-01 to 2012-06-30-4,188USD91
2012-01-01 to 2012-03-31-9,511USD91
2011-01-01 to 2011-12-31-38,636,723USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-31133,331,530USD
At 2012-12-31184,824,842USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,458USD365
2012-01-01 to 2012-12-31628,993USD366
2011-01-01 to 2011-12-311,987,873USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3173,663,457USD
At 2012-12-3162,470,225USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-12-315,435,473USD
At 2012-12-313,647,967USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-3183,212,702USD365
2012-01-01 to 2012-12-3150,724,787USD366
2011-01-01 to 2011-12-3138,827,746USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-10-01 to 2013-12-3113,533USD92
2013-01-01 to 2013-12-3157,898,971USD365
2013-07-01 to 2013-09-3013,501USD92
2013-04-01 to 2013-06-3018,607USD91
2013-01-01 to 2013-03-3112,259USD90
2012-10-01 to 2012-12-3110,518USD92
2012-01-01 to 2012-12-3135,670,418USD366
2012-07-01 to 2012-09-309,930USD92
2012-04-01 to 2012-06-308,806USD91
2012-01-01 to 2012-03-316,417USD91
2011-01-01 to 2011-12-3128,827,746USD365
2007-10-01 to 2007-10-31300,000USD31

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3136,155,509shares
At 2012-12-3135,919,019shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-3156,691USD
At 2012-12-3172,749USD
At 2011-12-31-6,264USD
At 2010-12-310USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-316,621,291USD
At 2012-12-315,300,759USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-312,781,865USD
At 2012-12-312,133,854USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-31114,961USD
At 2012-12-31546,313USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-3133,458USD
At 2012-12-3142,065USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-12-311,668,944USD
At 2012-12-311,902,910USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2013-12-310USD
At 2012-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-18,048,496USD365
2012-01-01 to 2012-12-31-17,212,745USD366
2011-01-01 to 2011-12-31-40,537,877USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-10-01 to 2013-12-316,704USD92
2013-01-01 to 2013-12-3125,313,731USD365
2013-07-01 to 2013-09-306,143USD92
2013-04-01 to 2013-06-306,211USD91
2013-01-01 to 2013-03-316,256USD90
2012-10-01 to 2012-12-314,950USD92
2012-01-01 to 2012-12-3115,054,369USD366
2012-07-01 to 2012-09-303,815USD92
2012-04-01 to 2012-06-303,195USD91
2012-01-01 to 2012-03-313,094USD91
2011-01-01 to 2011-12-3110,000,000USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-31674,725USD365
2012-01-01 to 2012-12-31358,367USD366
2011-01-01 to 2011-12-31262,518USD365

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-10-01 to 2013-12-31-28USD92
2013-01-01 to 2013-12-31-153,702USD365
2013-07-01 to 2013-09-30-108USD92
2013-04-01 to 2013-06-30-18USD91
2013-01-01 to 2013-03-310USD90
2012-10-01 to 2012-12-31-25USD92
2012-01-01 to 2012-12-31-947,834USD366
2012-07-01 to 2012-09-30-4USD92
2012-04-01 to 2012-06-30-994USD91
2012-01-01 to 2012-03-3175USD91
2011-01-01 to 2011-12-31-36,466USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-07-27 to 2011-08-0266,700,000USD7
2011-02-01 to 2011-02-0978,200,000USD9

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-312,508,687USD365
2012-01-01 to 2012-12-311,409,738USD366
2011-01-01 to 2011-12-310USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-386,241USD365
2012-01-01 to 2012-12-31524,936USD366
2011-01-01 to 2011-12-31943,024USD365

Inspect the source

Entity
ENDOCYTE INC / CIK 0001235007
Captured
SEC response SHA-256
fa7da76c073b3895ba6769212bf598e872bbf5f159d8c19a8ae123614d925339

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001235007.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))